Hope somebody can help me.
Mum diagnosed with stage iv NSCLC in May of last year with spinal meta. Oncologist said she was a prime candidate for pembrolizumab. After 5 treatments oncologist said it didn't work as primary tumour had grown.
oncologist the said that Mum had EGFR Exon18 and that Tarceva would be best option. After 3 months on tarceva Mum now has small mets on brain x 3 and two on liver. Oncologist now says that chemo only option.
i have done some reading which says that the ideal targeted drug for Exon18 mutation is Afatinib and suggested same to oncologist. She doesn't like to be challenged and was dismissive of afatinib as an option stating that side effects would be too severe despite the fact that dosage could be tailored to 20mg to mitigate risk of AEs.
I really believe that afatinib at 20mg is the best option for my Mum. How do I get the oncologist to give this option the appropriate attention.